Mar 5, 2026 08:31AM Tenaya Therapeutics partners with Alnylam for heart disease targets

Dec 18, 2025 06:33AM Tenaya Therapeutics Inc (TNYA) PT Lowered to $5 at Canaccord Genuity

Dec 15, 2025 06:42AM Tenaya Therapeutics Inc (TNYA) PT Lowered to $3 at H.C. Wainwright

Dec 12, 2025 12:18PM Tenaya Therapeutics Inc (TNYA) PT Lowered to $2 at Leerink Partners

Dec 12, 2025 11:29AM Increasing unusual option volume: XLB RCUS NXDR XLI BALL TNYA

Nov 10, 2025 07:09AM Tenaya Therapeutics, Inc. (TNYA) Tops Q3 EPS by 3c

Nov 4, 2025 05:35PM Tenaya Therapeutics to present TN-201 gene therapy data at AHA meeting

Aug 6, 2025 04:43PM Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 4c

Jul 30, 2025 08:32AM Tenaya gets safety clearance to advance heart gene therapy trials

May 7, 2025 04:30PM Tenaya Therapeutics, Inc. (TNYA) Misses Q1 EPS by 5c

Apr 25, 2025 06:56AM H.C. Wainwright Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)

Apr 24, 2025 02:08PM Tenaya Therapeutics (TNYA) Presents Interim Data from RIDGE Natural History and Seroprevalence Study

Mar 24, 2025 08:31AM Tenaya Therapeutics (TNYA) Publishes Preclinical Data Demonstrating TN-201 Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models

Mar 21, 2025 04:15PM Tenaya Therapeutics (TNYA) Files $300M Mixed Shelf

Mar 13, 2025 06:56AM Tenaya Therapeutics Inc (TNYA) PT Lowered to $6 at Canaccord Genuity

Mar 11, 2025 06:43AM Tenaya Therapeutics Inc (TNYA) PT Lowered to $5 at H.C. Wainwright

Mar 10, 2025 04:48PM Tenaya Therapeutics, Inc. (TNYA) Tops Q4 EPS by 3c

Mar 3, 2025 04:10PM Tenaya Therapeutics (TNYA) Announces Proposed Share Offering

Feb 4, 2025 06:43AM H.C. Wainwright Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)

Feb 3, 2025 08:30AM Tenaya Therapeutics (TNYA) Receives $8M Clinical Grant from California Institute for Regenerative Medicine

Jan 13, 2025 09:17AM Tenaya Therapeutics (TNYA) Announces 2025 Strategic Priorities and Anticipated Milestones

Dec 18, 2024 06:50AM H.C. Wainwright Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)

Dec 17, 2024 07:01AM Tenaya Therapeutics (TNYA) Reports Promising Early Data from MyPEAK-1 Phase 1b/2 Clinical Trial

Dec 16, 2024 04:32PM Tenaya Therapeutics (TNYA) to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday

Nov 26, 2024 07:04AM H.C. Wainwright Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)

Nov 6, 2024 04:23PM Tenaya Therapeutics, Inc. (TNYA) Tops Q3 EPS by 7c

Oct 18, 2024 07:50AM Piper Sandler Reiterates Overweight Rating on Tenaya Therapeutics Inc (TNYA)

Oct 18, 2024 06:46AM H.C. Wainwright Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)

Oct 18, 2024 06:23AM Canaccord Genuity Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)

Oct 18, 2024 05:47AM Leerink Partners Reiterates Outperform Rating on Tenaya Therapeutics Inc (TNYA)

Oct 17, 2024 04:31PM Tenaya Therapeutics (TNYA) Announces Updates on TN-201 Gene Therapy Program

Oct 1, 2024 06:50AM Canaccord Genuity Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)

Aug 9, 2024 07:28AM Tenaya Therapeutics, Inc. (TNYA) Tops Q2 EPS by 5c

Jul 8, 2024 10:48AM H.C. Wainwright Reiterates Buy Rating on Tenaya Therapeutics Inc (TNYA)

Jun 27, 2024 05:00PM Tenaya Therapeutics (TNYA) Announces Research Leadership Updates

Jun 10, 2024 06:25AM William Blair Starts Tenaya Therapeutics Inc (TNYA) at Outperform